Effect of cyclopamine on Nurr1 gene expression in LN229 cells
WANG Di, CHEN Yan, LIU Fei-Fei, LENG Shui-Long, LONG Da-Hong, HONG Le-Feng
Chinese Journal of Clinical Anatomy ›› 2012, Vol. 30 ›› Issue (5) : 539-542.
Effect of cyclopamine on Nurr1 gene expression in LN229 cells
Objective To investigate the effect of cyclopamine on the expression of Parkinson-related gene Nurr1 in malignant glioma cell line LN229. Methods Upon LPS stimulation, real time PCR was used to detect contents of SHH relational gene PTCH, Gli1and Nurr1 mRNA in LN229 cell. Western blotting was used to detect the impact of LPS on Nurr1 protein expression. Furthermore, the contents of both of Nurr1 and the downstream Inflammation factor IL-1β were detected after blocking SHH Signaling pathway with cyclopamine. Results Upon the LPS stimulation, the relational gene mRNA and Nurr1mRNA in LN229 cell elevated. LPS significantly elevated the expression of nurr1 protein. Contrast with the control group, it was significantly promoted on the expression of Nurr1 gene and the downstream Inflammation factor IL-1β at the level of transcription and translation after cyclopamine blocking. Conclusions The effects of cyclopamine on the Nurr1 gene expression in LN229 cell may be related to the activation of glial cells during the pathogenesis process of Parkinson's disease.
[1] Jankovic J. Parkinson's disease: clinical features and diagnosis
[J]. J Neurol Neurosurg Psychiatry, 2008, 79(4): 368-376.
[2] Teeling JL, Perry VH. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms
[J]. Neuroscience, 2009, 158(3): 1062-1073.
[3] Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration
[J]. Cell, 2010, 140(6): 918-934.
[4] Brown GC. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase
[J]. Biochem Soc Trans, 2007, 35(Pt 5): 1119-1121.
[5] Hartmann A, Hunot S, Hirsch EC. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
[J]. Exp Neurol, 2003, 184(2): 561-564.
[6] Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease
[J]. Br J Pharmacol, 2007, 150(8): 963-976.
[7] Meredith GE, Sonsalla PK, Chesselet MF. Animal models of Parkinson's disease progression
[J]. Acta Neuropathol, 2008, 115(4): 385-398.
[8] Saijo K, Winner B, Carson CT, et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death
[J]. Cell, 2009, 137(1): 47-59.
[9] Ji H, Miao J, Zhang X, et al. Inhibition of sonic hedgehog signaling aggravates brain damage associated with the down-regulation of Gli1, Ptch1 and SOD1 expression in acute ischemic stroke
[J]. Neurosci Lett, 2012, 506(1): 1-6.
[10] Dai RL, Zhu SY, Xia YP, et al. Sonic hedgehog protects cortical neurons against oxidative stress
[J]. Neurochem Res, 2011, 36(1): 67-75.
[11] Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation
[J]. Curr Mol Med, 2009, 9(7): 873-886.
[12]Mcmorrow JP, Murphy EP. Inflammation: a role for NR4A orphan nuclear receptors
[J] ? Biochem Soc Trans, 2011, 39(2): 688-693.
[13]Wan F, Lenardo MJ. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives
[J]. Cell Res, 2010, 20(1): 24-33.
[14]Cai X, Gong P, Huang Y, et al. Notch signalling pathway in tooth development and adult dental cells
[J]. Cell Prolif, 2011, 44(6): 495-507.
[15]Sims JR, Lee SW, Topalkara K, et al. Sonic hedgehog regulates ischemia/hypoxia-induced neural progenitor proliferation
[J]. Stroke, 2009, 40(11): 3618-3626.
[16]Sherman AE, Zavros Y. Role of Sonic Hedgehog signaling during progression from inflammation to cancer in the stomach
[J]. World J Gastrointest Pathophysiol, 2011, 2(6): 103-108.
[17] Heller E, Hurchla MA, Xiang J, et al. Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment
[J]. Cancer Res, 2012, 72(4): 897-907.
[18] 何穗芬，董为人，郝彦利，等. Sonic Hedgehog蛋白在帕金森病模型大鼠黑质中的表达
[J]. 解剖学研究, 2008, 30(05)：321-324.
[19]Dass B, Iravani MM, Jackson MJ, et al. Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- treated common marmosets
[J]. Neuroscience, 2002, 114(1): 99-109.
/
| 〈 |
|
〉 |
